2-237377222-G-A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_004369.4(COL6A3):c.2620C>T(p.Arg874*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000479 in 1,461,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004369.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bethlem myopathy 1AInheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Ullrich congenital muscular dystrophy 1CInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- dystonia 27Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
- Ullrich congenital muscular dystrophy 1AInheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004369.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL6A3 | NM_004369.4 | MANE Select | c.2620C>T | p.Arg874* | stop_gained | Exon 7 of 44 | NP_004360.2 | ||
| COL6A3 | NM_057167.4 | c.2002C>T | p.Arg668* | stop_gained | Exon 6 of 43 | NP_476508.2 | |||
| COL6A3 | NM_057166.5 | c.799C>T | p.Arg267* | stop_gained | Exon 4 of 41 | NP_476507.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL6A3 | ENST00000295550.9 | TSL:1 MANE Select | c.2620C>T | p.Arg874* | stop_gained | Exon 7 of 44 | ENSP00000295550.4 | ||
| COL6A3 | ENST00000472056.5 | TSL:1 | c.799C>T | p.Arg267* | stop_gained | Exon 4 of 41 | ENSP00000418285.1 | ||
| COL6A3 | ENST00000392004.7 | TSL:1 | c.2002C>T | p.Arg668* | stop_gained | Exon 6 of 8 | ENSP00000375861.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461152Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726918 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg874*) in the COL6A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL6A3 are known to be pathogenic (PMID: 26004199). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL6A3-related conditions. ClinVar contains an entry for this variant (Variation ID: 476512). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at